Candesartan Cilexetil EP Impurity H
Product Description
CAT No.
ALN-C011009
CAS No.
170791-09-0
Mol. F.
C52H48N6O6
Mol. Wt.
853
Stock
In Stock
Product Overview
Technical Data
Reference
RFQ
Product Overview
Chemical Name : Candesartan Cilexetil N1-Trityl Analog ; N1-Trityl Candesartan Cilexetil ; 2-Ethoxy-1-[[2′-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1′-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid 1-[[(cyclohexyloxy) carbonyl]oxy]ethyl ester ;
Smiles : O=C(O[C@@]([H])(C)OC(OC1CCCCC1)=O)C2=CC=CC(N=C3OCC)=C2N3CC(C=C4)=CC=C4C5=CC=CC=C5C6=NN=NN6C(C7=CC=CC=C7)(C8=CC=CC=C8)C9=CC=CC=C9
Technical Data
Reference
Investigation and structural elucidation of a process related impurity in candesartan cilexetil by LC/ESI-ITMS and NMR
Bhanu Ramana,u2217, Brajesh A. Sharmaa,b, Ganesh Mahale b, Dharmendra Singhb, Ashok KumarnJournal of Pharmaceutical and Biomedical Analysis 56 (2011) 256u2013263
Synergistic suppression of tumor angiogenesis by codelivering of VEGF targeted siRNA and candesartan mediated by functionalized carbon nanovectors
Xuefang Ding, Yujie Su, Cheng Wang, Fangrong Zhang, Kerong Chen, Yu Wang, Min Li, and Wei Wang – ACS Appl. Mater. Interfaces 2017, 9, 28, 23353–23369
Identification, Isolation, and Characterization of Five Potential Degradation Impurities in Candesartan Cilexetil Tablets
Arivozhi Mohan1,&, S. Shanmugavel1 , Ajay Goyal1 , B. R. Venkataraman2 , D. Saravanan – Chromatographia volume 69, pages1211–1220(2009)
RFQ